Skip to main content

Advertisement

Table 1 Characteristics of the advanced NSCLC patients

From: The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy

Characteristics n=28
Age (y) 71 ± 76
Gender  
Female 12
Male 16
Stage  
III A 3
IIIB 8
IV 17
Histology  
Adenocarcinoma 11
Squamous carcinoma 9
Not classified carcinoma 8
Mode of therapy  
CMV 14
MV 9
GC 5
  1. Abbreviations: CMV caboplatin + mitomycin c + Vinblastin, MV mitomycin c + Vinorelbin, GC gemcitabine + cisplatin.